136 related articles for article (PubMed ID: 12898010)
1. The effects of a specific growth hormone antagonist on overnight insulin requirements and insulin sensitivity in young adults with Type 1 diabetes mellitus.
Williams RM; Amin R; Shojaee-Moradie F; Umpleby AM; Acerini CL; Dunger DB
Diabetologia; 2003 Sep; 46(9):1203-10. PubMed ID: 12898010
[TBL] [Abstract][Full Text] [Related]
2. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
Acerini CL; Harris DA; Matyka KA; Watts AP; Umpleby AM; Russell-Jones DL; Dunger DB
Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
[TBL] [Abstract][Full Text] [Related]
3. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
Saukkonen T; Amin R; Williams RM; Fox C; Yuen KC; White MA; Umpleby AM; Acerini CL; Dunger DB
J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
[TBL] [Abstract][Full Text] [Related]
5. Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.
Amin R; Williams RM; Frystyk J; Umpleby M; Matthews D; Orskov H; Dalton RN; Dunger DB
Clin Endocrinol (Oxf); 2005 Feb; 62(2):137-44. PubMed ID: 15670188
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
Saukkonen T; Shojaee-Moradie F; Williams RM; Amin R; Yuen KC; Watts A; Acerini CL; Umpleby AM; Dunger DB
Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
[TBL] [Abstract][Full Text] [Related]
7. Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment.
Halldin MU; Brismar K; Tuvemo T; Gustafsson J
Clin Endocrinol (Oxf); 2002 Dec; 57(6):735-43. PubMed ID: 12460323
[TBL] [Abstract][Full Text] [Related]
8. Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus.
Pal BR; Phillips PE; Matthews DR; Dunger DB
Diabetologia; 1992 Jun; 35(6):542-9. PubMed ID: 1612227
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.
Simpson HL; Jackson NC; Shojaee-Moradie F; Jones RH; Russell-Jones DL; Sönksen PH; Dunger DB; Umpleby AM
J Clin Endocrinol Metab; 2004 Jan; 89(1):425-32. PubMed ID: 14715881
[TBL] [Abstract][Full Text] [Related]
10. The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with type 1 (insulin-dependent) diabetes mellitus.
Cheetham TD; Jones J; Taylor AM; Holly J; Matthews DR; Dunger DB
Diabetologia; 1993 Jul; 36(7):678-81. PubMed ID: 8359587
[TBL] [Abstract][Full Text] [Related]
11. IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp.
Carroll PV; Christ ER; Umpleby AM; Gowrie I; Jackson N; Bowes SB; Hovorka R; Croos P; Sönksen PH; Russell-Jones DL
Diabetes; 2000 May; 49(5):789-96. PubMed ID: 10905488
[TBL] [Abstract][Full Text] [Related]
12. Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegaly.
Higham CE; Rowles S; Russell-Jones D; Umpleby AM; Trainer PJ
J Clin Endocrinol Metab; 2009 Jul; 94(7):2459-63. PubMed ID: 19366854
[TBL] [Abstract][Full Text] [Related]
13. rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM.
Carroll PV; Umpleby M; Ward GS; Imuere S; Alexander E; Dunger D; Sönksen PH; Russell-Jones DL
Diabetes; 1997 Sep; 46(9):1453-8. PubMed ID: 9287046
[TBL] [Abstract][Full Text] [Related]
14. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
[TBL] [Abstract][Full Text] [Related]
15. Changes in free rather than total insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young healthy adults.
Yuen K; Frystyk J; Umpleby M; Fryklund L; Dunger D
J Clin Endocrinol Metab; 2004 Aug; 89(8):3956-64. PubMed ID: 15292333
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular triglyceride content is increased in IDDM.
Ebeling P; Essén-Gustavsson B; Tuominen JA; Koivisto VA
Diabetologia; 1998 Jan; 41(1):111-5. PubMed ID: 9498639
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) receptor blockade with a PEG-modified GH (B2036-PEG) lowers serum insulin-like growth factor-I but does not acutely stimulate serum GH.
Thorner MO; Strasburger CJ; Wu Z; Straume M; Bidlingmaier M; Pezzoli SS; Zib K; Scarlett JC; Bennett WF
J Clin Endocrinol Metab; 1999 Jun; 84(6):2098-103. PubMed ID: 10372717
[TBL] [Abstract][Full Text] [Related]
18. Low-dose IGF-I has no selective advantage over insulin in regulating glucose metabolism in hyperglycemic depancreatized dogs.
Fisher SJ; Shi ZQ; Lickley HL; Efendic S; Vranic M; Giacca A
J Endocrinol; 2001 Jan; 168(1):49-58. PubMed ID: 11139769
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long-term continuous subcutaneous insulin infusion therapy.
Donga E; van Dijk M; Hoogma RP; Corssmit EP; Romijn JA
Diabetes Metab Res Rev; 2013 Jan; 29(1):33-8. PubMed ID: 22936679
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
Laager R; Ninnis R; Keller U
J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
